ULTRA-LATE (>24 WEEKS) RESPONSE TO ANTI-CGRP MONOCLONAL ANTIBODIES IN MIGRAINE: A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY

被引：0

作者：

Aurilia, C. ^{[1
]}

Egeo, G. ^{[1
]}

Proietti, S. ^{[2
]}

Cevoli, S. ^{[3
]}

Colombo, B. ^{[4
]}

Messina, R. ^{[4
]}

Torelli, P. ^{[5
]}

D'Onofrio, F. ^{[6
]}

Vernieri, F. ^{[7
]}

Altamura, C. ^{[7
]}

Salerno, A. ^{[8
]}

Aguggia, M. ^{[9
]}

Grazzi, L. ^{[10
]}

Trimboli, M. ^{[11
]}

Mercuri, B.

Carnevale, A. ^{[12
]}

Zucco, M. ^{[13
]}

Di Clemente, L. ^{[13
]}

Albanese, M. ^{[14
]}

Finocchi, C. ^{[15
]}

Bono, F. ^{[16
]}

Frediani, F. ^{[17
]}

Filippi, M. ^{[4
]}

Bertuzzo, D.

Favoni, V

Di Fiore, P. ^{[17
]}

Bonassi, S. ^{[2
,18
]}

Barbanti, P. ^{[18
]}

机构：

[1] Headache & Pain Unit IRCCS San Raffaele Roma, Rome, Italy

[2] Clin & Mol Epidemiol IRCCS San Raffaele Roma, Rome, Italy

[3] IRCCS Ist Sci Neurol Bologna, Bologna, Italy

[4] Univ Vita Salute San Raffaele, Neurol Unit, IRCCS San Raffaele Sci Inst, Milan, Italy

[5] Univ Parma, Unit Neurol, Dept Med & Surg, Headache Ctr, Parma, Italy

[6] San Giuseppe Moscati Hosp, Headache Ctr, Neurol Unit, Avellino, Italy

[7] Policlin Univ, Headache & Neurosonol Unit, Campus Biomed, Rome, Italy

[8] San Giovanni Addolorata Hosp, Headache Ctr, Rome, Italy

[9] Headache Ctr Cardinal Massaia, Asti, Italy

[10] Fdn IRCCS Ist Neurol Carlo Besta, Headache Ctr, Neuroalgol Unit, Milan, Italy

[11] Magna Graecia Univ Catanzaro, Catanzaro, Italy

[12] San Filippo Neri Hosp, Headache Ctr, Rome, Italy

[13] San Camillo Forlanini Hosp, Headache Ctr, Rome, Italy

[14] Univ Hosp Tor Vergata, Reg Referral Headache Ctr, Neurol Unit, Rome, Italy

[15] San Paolo Hosp ASL 2 Savonese, Div Neurol, Savona, Italy

[16] AOU Mater Domini, Ctr Headache & Intracranial Pressure Disorders, Neurol Unit, Catanzaro, Italy

[17] ASST Santi Paolo Carlo, Headache Ctr, Milan, Italy

[18] San Raffaele Univ, Rome, Italy

来源：

HEADACHE | 2023年 / 63卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P-200

引用

页码：177 / 178

页数：2

共 50 条

[31] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
Marta Torres-Ferrús
Victor J. Gallardo
Alicia Alpuente
Edoardo Caronna
Eulalia Gine-Cipres
Patricia Pozo-Rosich
Journal of Neurology, 2021, 268 : 3789 - 3798
[32] External validation of the predictive model of response to anti-CGRP monoclonal antibodies in patients with migraine
Gonzalez Martinez, A.
Sanchez-Rodriguez, C.
Pagan, J.
Fernandez Lazaro, I.
Rodrigue-Vico, J. S.
Jaimes Sanchez, A.
Gomez Garcia, A.
Casas Limon, J.
Diaz de Teran, J.
Sastre Real, M.
Membrilla Lopez, J. A.
Latorre, G.
Calle de Miguel, C.
Gil Luque, S.
Trevino-Peinado, C.
Quintas Gutierrez, S.
Heredia, P.
Garcia Azorin, D.
Echavarria Iniguez, A.
Guerrero Peral, A. L.
Sierra-Mencia, A.
Gonzalez Garcia, N.
Porta-Etessam, J.
Gago-Viega, A.
JOURNAL OF HEADACHE AND PAIN, 2024, 25
[33] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
Torres-Ferrus, Marta
Gallardo, Victor J.
Alpuente, Alicia
Caronna, Edoardo
Gine-Cipres, Eulalia
Pozo-Rosich, Patricia
JOURNAL OF NEUROLOGY, 2021, 268 (10) : 3789 - 3798
[34] European multicenter study on the use of anti-CGRP monoclonal antibodies in real life for migraine prevention: study cohort description
Caronna, Edoardo
Jose Gallardo, Victor
Alpuente, Alicia
Torres-Ferrus, Marta
Huerta Villanueva, Mariano
Munoz, Albert
Campoy, Sergio
Cuadrado Godia, Elisa
Dorado, Laura
Obach, Victor
Fabregat, Neus
Rodriguez Vico, Jaime
Diaz de Teran, Javier
Membrilla, Javier
Pascual, Julio
Garate, Gabriel
Gago, Ana
Guerrero, Angel
Sanahuja, Jordi
Sanchez Soblechero, Antonio
Lozano Ros, Alberto
Irimia Sieira, Pablo
Sanchez del Rio, Margarita
Echeverria Urabayen, Amaya
Garcia Azorin, David
Gonzalez Osorio, Yesica
Gonzalez Quintanilla, Vicente
Lopez Bravo, Alba
Fernandez Lazaro, Iris
Quintas Gutierrez, Sonia
Gonzalez-Martinez, Alicia
Flores Pina, Belen
Manera Zorrilla-Lequerica, Paula
Jaimes Sanchez, Alex
Garcia Gomez, Andrea
Alvarez Escudero, Rocio
Oterino Duran, Agustin
Velasco Juanes, Fernando
Sifontes, Walter
Rodriguez Montolio, Joana
Nieves Castellanos, Candela
Olivier, Marina
Layos-Romero, Almudena
Andres Lopez, Alberto
Sanchez Caballero, Francisco
Beltran Blasco, Isabel
Millan Vazquez, Manuel
Lamas Perez, Raquel
Viguera Romero, Javier
Santos-Lasaosa, Sonia
CEPHALALGIA, 2023, 43 (1supp)
[35] Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date
Pellesi, Lanfranco
Guerzoni, Simona
Pini, Luigi Alberto
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (06): : 534 - 547
[36] Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
Grazzi, Licia
Giossi, Riccardo
Montisano, Danilo Antonio
Canella, Mattia
Marcosano, Marilena
Altamura, Claudia
Vernieri, Fabrizio
JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
[37] Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
Licia Grazzi
Riccardo Giossi
Danilo Antonio Montisano
Mattia Canella
Marilena Marcosano
Claudia Altamura
Fabrizio Vernieri
The Journal of Headache and Pain, 25
[38] Anti-CGRP monoclonal antibodies: migraine prevention in patients with psychiatric comorbidities
di Cola, Francesca Schiano
Ceccardi, Giulia
Caratozzolo, Salvatore
Bolchini, Marco
Di Pasquale, Michele
Rao, Renata
Padovani, Alessandro
CEPHALALGIA, 2023, 43 (1supp) : 252 - 253
[39] Safety concerns of treatment with anti-CGRP monoclonal antibodies in patients with migraine
van der Arend, Britt W. H.
van Veelen, Nancy
de Ruijter, Joelle E. T.
Olsen, Michael H.
van den Brink, Antoinette Maassen
Terwindt, Gisela M.
CEPHALALGIA, 2023, 43 (1supp) : 233 - 233
[40] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
Lovati, Carlo
Bernasconi, Gianna
Capogrosso, Chiara
Molteni, Laura
Giorgetti, Federica
Dell'Osso, Bernardo
Pantoni, Leonardo
NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5765 - 5767

← 1 2 3 4 5 →

ULTRA-LATE (&gt;24 WEEKS) RESPONSE TO ANTI-CGRP MONOCLONAL ANTIBODIES IN MIGRAINE: A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY

ULTRA-LATE (>24 WEEKS) RESPONSE TO ANTI-CGRP MONOCLONAL ANTIBODIES IN MIGRAINE: A MULTICENTER, PROSPECTIVE, OBSERVATIONAL STUDY